To investigate whether PLCβ and its downstream PKC signaling pathway mediate SLIT3-induced neuroblastoma differentiation, we employed the PLCβ inhibitor U-73122 [63, 64] and PKC inhibitor Ro 31–8220 [65, 66] for signaling inhibition. The gene discussed is PRRT2; the disease is neuroblastoma.